FDA Approved: MICAFUNGIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Micafungin (Hikma Pharmaceuticals USA Inc.), leading to changes/updates approved for this antifungal product's label…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infection Prophylaxis in Hematopoietic Stem Cell Transplant Recipients
• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Mycamine (Micafungin)

Snippet

SUPPL AP for MICAFUNGIN (MICAFUNGIN SODIUM)